Hunt, Camille K.
Al Khleifat, Ahmad
Burchill, Ella
Ederle, Joerg
Al-Chalabi, Ammar
Sreedharan, Jemeen http://orcid.org/0000-0002-8682-6844
Funding for this research was provided by:
Rosetrees Trust
Medical Research Council (MR/L501529/1; MR/R024804/1)
Economic and Social Research Council (ES/L008238/1)
Article History
Received: 8 January 2021
Accepted: 18 April 2021
First Online: 28 May 2021
Declarations
:
: Not applicable.
: Consent was obtained from the proband of the family described.
: Ammar Al-Chalabi is a consultant for Mitsubishi-Tanabe Pharma, GSK, and Chronos Therapeutics and chief investigator for clinical trials for Cytokinetics and OrionPharma. All other authors declare no competing interests.